Fresenius Kabi recalls Rifampin; China's 3SBio buys some small molecule manufacturing;

> Fresenius Kabi is voluntarily recalling two lots, or 7,593 vials, of Rifampin because they were out of specification for impurities and color. Recall

> Qualitest Pharmaceuticals is recalling 47,376 bottles of hydroxyzine hydrochloride because some identification codes are unreadable. Notice

> Chinese biotech 3SBio has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), in part to get its expertise in small molecule manufacturing. Release